Skip to content
PatientMatchFind trials

Screener

Eligibility screening

HC-7366 in Combination With Belzutifan (WELIREG™) in Patients With Renal Cell Carcinoma

Sponsored by HiberCell, Inc.Study detailsClinicalTrials.gov

20 US sites in AZ, CA, CO, CT +10

Before we begin

Who are you filling this out for?

Your answer affects how the questions are phrased.